Good Start Genetics, Inc.: Series A $18M

Posted in I - Series A, Q - 3Q10, R - NORTH EAST, X - Device (GYN), XX - MA

Good Start Genetics (Boston, MA) a development-stage pre-pregnancy diagnostic company focused on a panel of genetic disorders including those recommended by the American Congress of Obstetricians and Gynecologists and the American College of Medical Genetics, closed a $18M Series A financing. Participants include OrbiMed Advisors, Safeguard Scientifics and SV Life Sciences.

Jul

2009

Interlace Medical, Inc.: Series C $20M

Posted in I - Series C, Q - 2Q09, R - NORTH EAST, X - Device (GYN), XX - MA

Interlace Medical (Framingham, MA) a near commercial-stage gynecological medical device company focused MIS removal of intrauterine fibroids and polyps, closed a $20M Series C financing. Participants include Baird Venture Partners, HLM Venture Partners, Hambrecht & Quist Capital Management, Aperture Venture Partners, New Leaf Venture Partners and Spray Venture Partners.

May

2009

CerviLenz, Inc.: Series A $4M

Posted in I - Series A, Q - 2Q09, R - MID WEST, X - Device (GYN), X - Device (OBY), XX - OH

CerviLenz (Chagrin Falls, OH) a commercial-stage developer of a diagnostic single-use medical device for measuring cervical length to determine the risk of pre-term birth in pregnant women, closed a $4M Series A financing. Participants include Arboretum Ventures and Chrysalis Ventures.

Nov

2008

NeoTract, Inc.: Series A $7.4M

Posted in I - Series A, Q - 2Q08, R - WEST, X - Device (GYN), X - Device (Urology)

NeoTract, Inc. (Pleasanton, CA) medical device company focused on urological and gynecological disorders, closed a $7.4M Series A financing. Participants include New Enterprise Associates.

to top of page...